Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Y-mAbs Therapeutics, Inc. | SVP & CHIEF MEDICAL OFFICER | Common Stock | 33.9K | $560K | $16.53 | Mar 5, 2024 | Direct |
Y-mAbs Therapeutics, Inc. | SVP & CHIEF MEDICAL OFFICER | Common Stock | 4.27K | $70.5K | $16.53 | Mar 5, 2024 | By Spouse and minor |
Y-mAbs Therapeutics, Inc. | SVP & CHIEF MEDICAL OFFICER | Employee Stock Option (right to buy) | 35.7K | Jan 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics, Inc. | Mar 5, 2024 | 1 | -$28.3K | 4 | Mar 7, 2024 | SVP & CHIEF MEDICAL OFFICER |
YMAB | Y-mAbs Therapeutics, Inc. | Jan 18, 2024 | 2 | $0 | 4 | Jan 22, 2024 | SVP & CHIEF MEDICAL OFFICER |
YMAB | Y-mAbs Therapeutics, Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | SVP & CHIEF MEDICAL OFFICER |
YMAB | Y-mAbs Therapeutics, Inc. | Jan 17, 2023 | 2 | $0 | 4 | Jan 19, 2023 | SVP & CHIEF MEDICAL OFFICER |
YMAB | Y-mAbs Therapeutics, Inc. | Nov 15, 2022 | 1 | $5.88K | 4 | Nov 16, 2022 | SVP & CMO |
YMAB | Y-mAbs Therapeutics, Inc. | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | SVP & CMO |
YMAB | Y-mAbs Therapeutics, Inc. | Dec 14, 2021 | 1 | $0 | 4 | Dec 16, 2021 | SVP & CMO |
YMAB | Y-mAbs Therapeutics, Inc. | Aug 12, 2021 | 1 | $41.1K | 4 | Aug 13, 2021 | SVP & CMO |